Fzata, Inc. is a clinical biotherapeutics company based in Halethorpe, Maryland. They have developed a proprietary platform called BioPYM™ that uses yeast micro-factories to produce biologic therapeutics in the gut. By replacing injections with oral capsules, Fzata aims to improve patient accessibility, compliance, and outcomes for gastrointestinal disorders and other conditions. Founded in 2015, the company is focused on making biologic therapies more affordable and convenient for patients.